2nd Rapid Medical Product Safety Symposia
June 23, 9-10:30am ET
Registration is now available, Click here to register today!
| 9:00 am | Opening remarks: Sebastian Schneeweiss, MD, ScD FISPE, Past President ISPE Miriam Sturkenboom, PhD,PharmD, FISPE, Erasmus University Medical Center |
| 9:10 am | An abrupt cluster of childhood narcolepsy in Finland after the AH1N1 pandemic and pandemic vaccination Hanna Nohynek, MD, PhD, et al. National Institute for Health and Welfare Heldsinki, Finland |
| 9:25 am | A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - A first and preliminary report, by the Medical Products Agency Ingemar Persson, MD, PhD, et al. Medical Product Agency Uppsala, Sweden |
| 9:40 am | Narcolepsy, H1N1 vaccination and infections: the VAESCO investigations Jan Bonhoeffer, MD, et al. Brighton Foundation, University Children's Hospital, Basel, Switzerland |
| 9:55 am | Discussion: Strengths and Weaknesses with a focus on Diagnostic Bias and Confounding Miriam Sturkenboom, PhD,PharmD, FISPE, Erasmus University Medical Center |
| 10:15 am | Study of Acute Liver Transplant (SALT): Main results of the 7-country case-population study on acute liver failure associated with NSAIDs and paracetamol Sinem Ezgi Gulmez, M.D., PhD, et al. Université Bordeaux Segalen, Bordeaux, France |
| 10:30 am | Conclusion: Miriam Sturkenboom, PhD,PharmD, FISPE, Erasmus University Medical Center |
2011/2012 Rapid Symposia Editorial Board and peer review:
| Sebastian Schneeweiss (Chair) | Harvard U | Boston |
| Bram Hartzema (Co-Chair) | U of Florida | Gainesville |
| Colin Dormuth | U of British Columbia | Vancouver |
| Bruce Fireman | Kaiser Permanente | Oakland |
| Bert Leufkens | Utrecht University | Utrecht |
| Muhamad Mamdani | U of Toronto | Toronto |
| Giampiero Mazzaglia | College of GPs | Florence |
| Fredrick Nyberg | Astra Zeneca | Goteborg |
| Robert Reynolds | Pfizer | New York |
| Libby Roughead | U of South Australia | Adelaide |
| Cristina L Varas-Lorenzo | RTI Health Solutions | Barcelona |
| Patrick Waller | Patrick Waller Ltd | Southampton |
The International Society for Pharmacoepidemiology (ISPE) is excited to announce the second ISPE-sponsored rapid-turnaround platform for scientific discussion and publication. ISPE recognizes the need for an even faster-turn-around dissemination of findings from the various national and trans-national active medical product safety monitoring programs. These new Rapid Medical Product Safety Symposia were developed by an ISPE Task Force under the leadership of Bram Hartzema, FISPE.
What?
A 90-minute Webinar Symposium will focus on clinical findings and methodological improvements of active medical product surveillance programs of national or trans-national scale. We plan on having 4 or 5 presentation.
The rapid cycle information dissemination efforts should focus on information resulting from research that provide the scientific underpinnings of active medical product safety surveillance, advance the research agenda of active medical product surveillance, and present current medical product safety surveillance findings for replication by other researchers or contribute in a meaningful way to clinical practice.
Who?
Presenters:
Initially the presenters recruit themselves from the national and trans-national active drug safety surveillance programs from around the world by submitting abstracts. The principal investigators (PI) of these programs constitute the Program Committee, and they will distribute the call for abstracts to their respective program investigators. Abstracts from outside the programs are not envisioned for the pilot symposium. One or two PIs will take the lead in planning a symposium. Professor Miriam Sturkenboom, FISPE has agreed to leading this 2nd symposium. We anticipate that the leadership of each symposium rotate and include all interested programs.
Peer Review:
ISPE has organized an independent peer review system through an Editorial Board consisting of 8 ISPE members including a chairperson (Sebastian Schneeweiss, FISPE).
Audience:
The 2nd symposium is open for ISPE members and guests for no charge.
It is targeted towards researchers, regulators or industry representatives working on or interpreting output of national and trans-national active medical product safety monitoring programs.
Publication:
Accepted abstracts will be posted on the ISPE website and can be referenced as peer-reviewed material. At this point, posting the actual slide presentations is not anticipated. The presentations will not be recorded to encourage exchange of ideas and opinions.
When?
The 2nd symposium will be on June 23 at 9:00 AM EST (3:00PM MET, 6:00AM PST) and will last 90 minutes. Registration will start June 1.
ISPE anticipates sponsoring 3-4 Rapid Symposia per year depending on demand.
